Brickell Biotech Inc
Change company Symbol lookup
Select an option...
BBI Brickell Biotech Inc
VTOL Bristow Group Inc
VTRS Viatris Inc
MSFT Microsoft Corp
NTB Bank of N T Butterfield & Son Ltd
CHN China Fund, Inc.
IGR CBRE Global Real Estate Income Fund
SURRY Sun Art Retail Group Ltd
VPV Invesco Pennsylvania Value Municipal Income Trust
HLBZ Helbiz Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Brickell Biotech, Inc. is a clinical-stage pharmaceutical company engaged in developing prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases. The Company’s pipeline combines several development-stage candidates and a cutting-edge platform with autoimmune and inflammatory disorders program for the treatment of primary axillary hyperhidrosis. Its products include Cialis, Taltz, Gemzar, Prozac, Cymbalta and Juvederm. Its lead development-stage program, BBI-02, is a Phase I ready, highly selective, and orally bioavailable DYRK1A inhibitor that has demonstrated in various preclinical models, including atopic dermatitis and rheumatoid arthritis. BBI-10, the Company’s lead early-stage STING inhibitor candidate, is a novel, potent, and orally available covalent STING inhibitor that specifically targets the palmitoylation site of STING, which allows to inhibit both wild-type STING and gain-of-function mutants.

Premarket

Last Trade
Delayed
$3.50
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$3.50
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
3,011

10-day average volume:
472,875
3,011

Lifshitz Law PLLC Announces Investigation of CTEK, SIMO, MANT, and VMW

7:02 pm ET June 13, 2022 (Globe Newswire) Print

EQNX::TICKER_START (NYSE:CTEK),(NASDAQ:SIMO),(NASDAQ:MANT),(NYSE:VMW), EQNX::TICKER_END

CynergisTek, Inc. (NYSE: CTEK)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of CTEK to Clearwater Compliance LLC for $1.25 per share in cash.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

Silicon Motion Technology Corporation (NASDAQ: SIMO)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of SIMO to MaxLinear, Inc. for $93.54 in cash and 0.388 shares of MaxLinear common stock for each share of SIMO owned.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ManTech International Corporation (NASDAQGS: MANT)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of MANT to a private equity consortium led by The Carlyle Group Inc. for $96.00 in cash per share of MANT owned.

If you are an investor, and would like information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

VMware, Inc. (NYSE: VMW)

Lifshitz Law PLLC announces investigation into possible breach of fiduciary duties in connection with the sale of VMW to Broadcom Inc. Under the terms of the proposed transaction, shareholders of VMW will elect to receive either $142.50 in cash or 0.2520 shares of Broadcom common stock for each share of VMW they own.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.

ATTORNEY ADVERTISING.(C) 2022 Lifshitz Law PLLC. The law firm responsible for this advertisement is Lifshitz Law PLLC, 1190 Broadway, Hewlett, New York 11557, Tel: (516)493-9780. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact:

Joshua M. Lifshitz, Esq.

Lifshitz Law PLLC

Phone: 516-493-9780

Facsimile: 516-280-7376

Email: info@jlclasslaw.com

https://ml.globenewswire.com/media/MzU2YTc3MDEtODlhMy00NTBmLTllNGYtOGUxYTZhYjlhZGE1LTEyMTY1ODk=/tiny/Lifshitz-Law-Firm-P-C-.png

https://ml.globenewswire.com/media/MzU2YTc3MDEtODlhMy00NTBmLTllNGYtOGUxYTZhYjlhZGE1LTEyMTY1ODk=/tiny/Lifshitz-Law-Firm-P-C-.png

comtex tracking

COMTEX_408631514/2010/2022-06-13T19:02:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.